Published in Lancet on February 25, 1995
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet (2007) 6.20
New antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ (1996) 4.73
Seizure recurrence and remission after switching antiepileptic drugs. Epilepsia (2012) 1.24
Multiple treatment comparisons in epilepsy monotherapy trials. Trials (2007) 1.14
Prioritizing children's medicines for research: a pharmaco-epidemiological study of antiepileptic drugs. Br J Clin Pharmacol (2007) 1.09
Adverse antiepileptic drug effects: toward a clinically and neurobiologically relevant taxonomy. Neurology (2009) 1.05
Validation of a population pharmacokinetic model for adjunctive lamotrigine therapy in children. Br J Clin Pharmacol (2000) 0.99
Fortnightly review: drug treatment of epilepsy. BMJ (1999) 0.99
Single Unprovoked Seizures. Curr Treat Options Neurol (2004) 0.98
Epilepsy in elderly people. BMJ (2005) 0.95
Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care. Curr Neuropharmacol (2009) 0.90
Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service. Br J Clin Pharmacol (1998) 0.90
The promise of new antiepileptic drugs. Br J Clin Pharmacol (2002) 0.89
Diffusion of the new antiepileptic drug lamotrigine in Dutch clinical practice. Eur J Clin Pharmacol (2004) 0.86
New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety? Ther Adv Drug Saf (2011) 0.85
Response to Early AED Therapy and Its Prognostic Implications. Epilepsy Curr (2002) 0.84
The Art of Managing Conversions between Antiepileptic Drugs: Maximizing Patient Tolerability and Quality of Life. Pharmaceuticals (Basel) (2010) 0.79
Outcomes of sustained-release formulation of valproate and topiramate monotherapy in patients with epilepsy: a multi-centre, cohort study. PLoS One (2012) 0.78
Treatment of epilepsy in daily clinical practice: have outcomes improved over the past 10 years? J Neurol (2013) 0.78
New drugs for the treatment of epilepsy: a practical approach. Postgrad Med J (2004) 0.78
Importance of competing risks in the analysis of anti-epileptic drug failure. Trials (2007) 0.78
Pharmacotherapeutic and Non-Pharmacological Options for Refractory and Difficult-to-Treat Seizures. J Cent Nerv Syst Dis (2012) 0.77
Lamotrigine versus carbamazepine in epilepsy. Lancet (1995) 0.77
Drug selection for the newly diagnosed patient: when is a new generation antiepileptic drug indicated? J Neurol (2004) 0.77
Lamotrigine pharmacokinetic evaluation in epileptic patients submitted to VEEG monitoring. Eur J Clin Pharmacol (2006) 0.77
Complex Partial Seizures in Adults. Curr Treat Options Neurol (1999) 0.76
The new antiepileptic drugs. Arch Dis Child (1996) 0.76
The association between oxcarbazepine-induced maculopapular eruption and HLA-B alleles in a northern Han Chinese population. BMC Neurol (2013) 0.76
Response to First AED. Epilepsy Curr (2002) 0.75
Lamotrigine versus carbamazepine in epilepsy. Lancet (1995) 0.75
Long-term effect of antiepileptic drug switch on serum lipids and C-reactive protein. Epilepsy Behav (2016) 0.75
Lamotrigine versus carbamazepine in epilepsy. Lancet (1995) 0.75
Lamotrigine versus carbamazepine in epilepsy. Lancet (1995) 0.75
Treatment of epilepsy in China: Formal or informal. Neural Regen Res (2013) 0.75
Therapeutic Index Estimation of Antiepileptic Drugs: A Systematic Literature Review Approach. Clin Neuropharmacol (2016) 0.75
Lamotrigine versus carbamazepine in epilepsy. Lancet (1995) 0.75
Primary Generalized Epilepsies. Curr Treat Options Neurol (2000) 0.75
Osteomalacia with long-term anticonvulsant therapy in epilepsy. Br Med J (1970) 5.88
Disturbance of calcium metabolism by anticonvulsant drugs. Br Med J (1970) 5.81
Lamotrigine. Lancet (1992) 2.97
Serum-phenytoin levels in management of epilepsy. Lancet (1975) 2.36
Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia (1999) 2.29
Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy. Lancet (1984) 2.20
Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q. Hum Mol Genet (1997) 2.02
A pharmacodynamic evaluation of midazolam as an antiepileptic compound. J Neurol Neurosurg Psychiatry (1986) 1.77
Status epilepticus in adults. Lancet (1990) 1.77
The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentration. Br J Clin Pharmacol (1981) 1.63
Controlled trial of lamotrigine (Lamictal) for refractory partial seizures. Epilepsia (1989) 1.62
Quality control in drug measurement. Ther Drug Monit (1980) 1.56
Water intoxication in epileptic patients receiving carbamazepine. J Neurol Neurosurg Psychiatry (1978) 1.56
Liver enzyme induction by anticonvulsant drugs, and its relationship to disturbed calcium and folic acid metabolism. J Clin Pharmacol (1973) 1.54
Adrenergic control of tendon jerk reflexes in man. Br J Pharmacol (1973) 1.54
Absorption of diazepam from the rectum and its effect on interictal spikes in the EEG. Epilepsia (1982) 1.50
Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group. Epilepsy Res (1997) 1.49
Clinical pharmacokinetics of phenytoin. Clin Pharmacokinet (1979) 1.42
Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects. Clin Pharmacol Ther (1981) 1.42
Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia (1997) 1.39
Acute effects of intravenous phenytoin on the frequency of inter-ictal spikes in man. Br J Clin Pharmacol (1983) 1.36
The response of essential tremor to propranolol: evaluation of clinical variables governing its efficacy on prolonged administration. J Neurol Neurosurg Psychiatry (1983) 1.36
Metoprolol and propranolol in essential tremor: a double-blind, controlled study. J Neurol Neurosurg Psychiatry (1981) 1.35
Plasma protein binding interaction between phenytoin and valproic acid in vitro. Br J Clin Pharmacol (1978) 1.34
Clobazam as adjunctive treatment in refractory epilepsy. Br Med J (Clin Res Ed) (1983) 1.31
Phenylethylmalonamide in essential tremor. A double-blind controlled study. J Neurol Neurosurg Psychiatry (1981) 1.31
Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs. Br J Clin Pharmacol (1979) 1.30
Effect of single doses of sodium valproate on serum phenytoin levels and protein binding in epileptic patients. Clin Pharmacol Ther (1980) 1.29
Attitudes of GPs to the care of people with epilepsy. Fam Pract (1998) 1.29
Theophylline: biochemical pharmacology and pharmacokinetics. J Int Med Res (1979) 1.28
Saccadic eye movement analysis as a measure of drug effects on human psychomotor performance. Br J Clin Pharmacol (1984) 1.27
Reduction of free testosterone by antiepileptic drugs. Br Med J (Clin Res Ed) (1982) 1.26
Phenytoin intoxication induced by sulthiame in epileptic patients. J Neurol Neurosurg Psychiatry (1974) 1.26
Difference in the central actions of phenytoin and phenobarbitone in man, measured by critical flicker fusion threshold. Eur J Clin Pharmacol (1973) 1.25
Involuntary movements caused by phenytoin intoxication in epileptic patients. J Neurol Neurosurg Psychiatry (1975) 1.24
A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients. Br J Clin Pharmacol (1984) 1.24
A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures. Epilepsy Res (1990) 1.24
The framework of medical care for epilepsy. Health Trends (1987) 1.22
Effect of a single oral dose of propranolol on essential tremor: a double-blind controlled study. Ann Neurol (1983) 1.19
Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients. Br J Clin Pharmacol (1979) 1.15
Methods of assessment of antiepileptic drugs. Br J Clin Pharmacol (1981) 1.14
Oral phenytoin pharmacokinetics during omeprazole therapy. Br J Clin Pharmacol (1987) 1.13
Effect of age, height, weight and sex on serum phenytoin concentration in epileptic patients. Br J Clin Pharmacol (1975) 1.13
Interactions with antiepileptic drugs. Drugs (1977) 1.12
Drug interactions with phenytoin. Drugs (1981) 1.12
The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction. Epilepsia (1999) 1.11
A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. Epilepsy Res (1996) 1.10
Reversal of competitive neuromuscular blockade by RX 67668 in normal volunteers. Br J Pharmacol (1972) 1.09
The effect of lamotrigine, a novel anticonvulsant, on interictal spikes in patients with epilepsy. Br J Clin Pharmacol (1986) 1.07
Should we routinely measure free plasma phenytoin concentration? Br J Clin Pharmacol (1984) 1.07
Rectal absorption of diazepam in epileptic children. Arch Dis Child (1982) 1.07
Effect of low-dose phenobarbitone on five indirect indices of hepatic microsomal enzyme induction and plasma lipoproteins in normal subjects. Br J Clin Pharmacol (1981) 1.05
Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy. Epilepsy Res (1987) 1.04
The action of general anaesthetic agents on root responses of the frog isolated spinal cord. Br J Pharmacol (1969) 1.04
Gallbladder cancer presenting with acute cholecystitis: a population-based study. Surg Endosc (2005) 1.04
Pharmacokinetics of the hypnotic benzodiazepine, temazepam. Br J Clin Pharmacol (1979) 1.04
When should plasma drug levels be monitored? Drugs (1979) 1.03
A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme-inducing drugs. Br J Clin Pharmacol (1980) 1.01
An efficient technique for determining characteristics of saccadic eye movements using a mini computer. J Biomed Eng (1981) 1.00
Single dose pharmacokinetic study of clobazam in normal volunteers and epileptic patients. Br J Clin Pharmacol (1984) 0.98
The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy. Contraception (1980) 0.98
Benzodiazepines impair smooth pursuit eye movements. Br J Clin Pharmacol (1983) 0.98
Response of skin thickness and metacarpal index to estradiol therapy in postmenopausal women. Obstet Gynecol (1987) 0.97
Bioavailability of diazepam after intravenous, oral and rectal administration in adult epileptic patients. Br J Clin Pharmacol (1982) 0.97
A method for studying spinal pharmacology in man. Br J Pharmacol (1970) 0.96
Acute effect of phenytoin on serum folate concentration. Br J Pharmacol (1971) 0.95
Sudden death and epilepsy. Lancet (1990) 0.95
Anticonvulsant osteomalacia. Br Med J (1971) 0.95
Serum protein binding of valproic acid and its displacement by palmitic acid in vitro. Br J Clin Pharmacol (1979) 0.94
Micro-vacuolation in rat brains after long term administration of GABA-transaminase inhibitors. Comparison of effects of ethanolamine-O-sulphate and vigabatrin. Biochem Pharmacol (1987) 0.94
Juvenile myoclonic epilepsy. BMJ (1992) 0.93
Rate of entrance of benzodiazepines into the brain determined by eye movement recording. Br J Clin Pharmacol (1983) 0.93
The comparative enzyme-inducing properties of antiepileptic drugs [proceedings]. Br J Clin Pharmacol (1979) 0.92
Two dimensional immunoelectrophoresis of human serum proteins for the investigation of protein drugs. Br J Pharmacol (1972) 0.92
The effects of sucralfate upon phenytoin absorption in man. Br J Clin Pharmacol (1985) 0.92
Controlled study of metoprolol and propranolol during prolonged administration in patients with essential tremor. J Neurol Neurosurg Psychiatry (1982) 0.92
Predicting phenytoin dose - a revised nomogram. Ther Drug Monit (1979) 0.92
A clinical trial of single dose rectal and oral administration of diazepam for the prevention of serial seizures in adult epileptic patients. J Neurol Neurosurg Psychiatry (1984) 0.91
Propranolol and sotalol as antagonists of isoproterenol-enhanced physiologic tremor. Clin Pharmacol Ther (1981) 0.91
Decreased serum protein binding of phenytoin in late pregnancy. Lancet (1980) 0.91
Lack of hepatic enzyme inducing effect of sodium valproate. Br J Clin Pharmacol (1979) 0.91
Drug estimation in the treatment of epilepsy. Proc R Soc Med (1974) 0.90
Pheneturide, a more potent liver enzyme inducer in man than phenobarbitone? Br J Pharmacol (1973) 0.90
The tremorolytic action of beta-adrenoceptor blockers in essential, physiological and isoprenaline-induced tremor is mediated by beta-adrenoceptors located in a deep peripheral compartment. Br J Clin Pharmacol (1985) 0.89
Pharmacokinetics and pharmacodynamics of the ace inhibitor benazepril hydrochloride in the elderly. Eur J Clin Pharmacol (1990) 0.89
Multiorgan failure and disseminated intravascular coagulation in severe convulsive seizures. Lancet (1992) 0.89
Retroperitoneal fibrosis associated with timolol. Lancet (1983) 0.89
Specific oculomotor deficits after amylobarbitone. Psychopharmacology (Berl) (1983) 0.89
Mutual interaction between remacemide hydrochloride and phenytoin. Epilepsy Res (1997) 0.88
Quantitative assessment of smooth-pursuit eye movements in healthy and epileptic subjects. J Neurol Neurosurg Psychiatry (1980) 0.88
Steady-state pharmacokinetics of phenytoin from routinely collected patient data. Clin Pharmacokinet (1983) 0.88
Mutual interaction between remacemide hydrochloride and carbamazepine: two drugs with active metabolites. Epilepsia (1996) 0.88
Effect of age and gender on pharmacokinetics of atorvastatin in humans. J Clin Pharmacol (1996) 0.88
Bioavailability and dissolution of proprietary and generic formulations of phenytoin. J Neurol Neurosurg Psychiatry (1992) 0.87
The effect of oral contraceptive steroids and enzyme inducing drugs on sex hormone binding globulin capacity in women [proceedings]. Br J Clin Pharmacol (1980) 0.87
A comparison of the acute effect of single doses of vigabatrin and sodium valproate on photosensitivity in epileptic patients. Epilepsy Res (1989) 0.87
Serum protein binding and free concentration of phenytoin and phenobarbitone in pregnancy. Br J Clin Pharmacol (1982) 0.87
Altered drug binding to serum proteins in pregnant women: therapeutic relevance. J R Soc Med (1981) 0.87
Human safety of lamotrigine. Epilepsia (1991) 0.86